The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System
Abstract
CB1 cannabinoid receptors appear to mediate most, if not all of the psychoactive effects of delta-9-tetrahydrocannabinol and related compounds. This G protein-coupled receptor has a characteristic distribution in the nervous system: It is particularly enriched in cortex, hippocampus, amygdala, basal ganglia outflow tracts, and cerebellum--a distribution that corresponds to the most prominent behavioral effects of cannabis. In addition, this distribution helps to predict neurological and psychological maladies for which manipulation of the endocannabinoid system might be beneficial. CB1 receptors are primarily expressed on neurons, where most of the receptors are found on axons and synaptic terminals, emphasizing the important role of this receptor in modulating neurotransmission at specific synapses. While our knowledge of CB1 localization in the nervous system has advanced tremendously over the past 15 years, there is still more to learn. Particularly pressing is the need for (1) detailed anatomical studies of brain regions important in the therapeutic actions of drugs that modify the endocannabinoid system and (2) the determination of the localization of the enzymes that synthesize, degrade, and transport the endocannabinoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CB1R is the most densely expressed in the brain and is present at high levels in corticolimbic regions mediating anxiety, including the medial prefrontal cortex (mPFC) and hippocampus, as well as the BLA [11,14]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [14]
Citations
Cites
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Interneurons of the hippocampus
Freund, T. F., & Buzsáki, G. (1998) · Hippocampus · doi:10.1002/(sici)1098-1063(1996)6:4 · Cited by 3,478
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Role of Endogenous Cannabinoids in Synaptic Signaling
Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,616
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Self-citationBrain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218
Self-citationCB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,085
Flagged first, then by citations
Research works printed but not linked: 1
- Riegal AC, Williams JT, Lupica CR (2003) Cananbionid CB1 receptors inhibit GABA-Bmediated synaptic currents in midbrain dopaminergic neurons. Soc Neurosci Abstr 33:462466
Cited by
Sorted by citations
Items 701–751 of 751
Iversen, L. L. (2019) · Oxford University Press eBooks · doi:10.1093/oso/9780190846848.002.0005
Beyond dopamine: exploring endocannabinoids in Parkinson’s disease
Basu, D., Yang, N., Ding, J., Wang, L., Liu, Z., Tang, B., & Cai, H. (2024) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2024.18
Cannabinoid ligands and receptors
Beressa, T. B., Gadisa, D. A., & Taye, G. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95927-8.00014-1
Shah, S. S. H., Latif, S., & Qureshi, R. (2024) · Current Bioactive Compounds · doi:10.2174/0115734072320482240902080452
Watt, G., & Karl, T. (2025) · Springer eBooks · doi:10.1007/978-3-031-87990-6_14
Cognitive Effects of Adolescent and Young Adult Regular Cannabis Use
Lisdahl, K. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-87990-6_12
BI-5756 Reduces Graft-Versus-Host Disease Through CB1-Mediated Treg Upregulation
Kim, S., Dania, A.-J., Lim, S., & Choi, J. (2025) · Molecules · doi:10.3390/molecules30173517
Recreational substance use is linked with difficulty in recalling personal experiences
Levent, A., & Davelaar, E. J. (2025) · Scientific Reports · doi:10.1038/s41598-025-13800-y · Cited by 1
Cannabis sativa extracts reduce inclusion formation in a cell model of alpha-synuclein aggregation
Cruz, T. D. A., Osorio, R. D. P., Epifânio, N. M. D. M., Merghani, M. M., Pereira, M. D., Chaves, D. S. D. A., Outeiro, T. F., & Riger, C. J. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.106968
Potential mechanisms of endocannabinoid release
Lupica, C. R. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00006-2
Harloe, J. P. (2008) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/3826-5762
Saumell-Esnaola, M., Elejaga-Jimeno, A., Echeazarra, L., Roman, L. B., Barrondo, S., López de Jesús, M., González‐Burguera, I., Gómez‐Caballero, A., Goicolea, M. A., Sallés, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21130052
Development of Canna-Products and Their Physiochemical Analysis
Sajid, A., Kalsoom, U., Naeem, M., Anwar, R., Siddique, A., Bukhari, S. H., & Munawar, K. (2025) · Indus journal of bioscience research. · doi:10.70749/ijbr.v3i9.2360
Black, T., Boseley, R. E., Quirk, A., Young, K. M., Baccetto, S. L., Muyres, B. D., Laprairie, R. B., & Howland, J. G. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00752 · Cited by 1
Comparative Pharmacokinetics of Natural, Endogenous, and Synthetic Cannabinoids
Waheed, T., Han, S. Y., & Choi, Y. H. (2026) · Drug Targets and Therapeutics · doi:10.58502/dtt.25.0017
Implication du système endocannabinoïde dans la dépendance à la nicotine
Simonnet, A. (2011) · theses.fr (ABES) · doi:10.70675/d1ec2e23zef37z47ebz990bzf2a2515f5892
Couto, M. G. G. D., Grope, A. S. R., Coutinho, G. L. F., Carvalho, L. S., Costa, L. A., Bandeira, J. R. B. V., Pereira, I. M. B., & Tolentino, M. V. C. (2026) · Revista Brasileira de Criminalística · doi:10.15260/rbc.v15i1.1022
Rodriguez, A. G. (2016) · theses.fr (ABES) · doi:10.70675/ecd0f3cbz19d7z406bza88eze6d1c4e9be0e
Reelin in vulnerability and sex-dependent maturational trajectories of the prefrontal cortex
Silva-Hurtado, T. J. (2021) · theses.fr (ABES) · doi:10.70675/ecf0031ez1ac8z4688za735za4cd9acfc52c
Cross-talk between melatonin type 1 and cannabinoid type 1 receptors
Cui, Y. (2022) · theses.fr (ABES) · doi:10.70675/3dab490dz44d1z43a6za1e7zf7daf8357d93
Cannabinoids in Motor Control: From Receptor Distribution to Motor Disorders
Faganeli, D., & Lipnik‐Štangelj, M. (2026) · Biomedicines · doi:10.3390/biomedicines14040844
Cannabidiol for the Treatment of Neurodevelopmental Disorders: Focus on Schizophrenia and Autism
Martino, S. D., Coppola, I., Drago, F., Tartaglione, A. M., & Micale, V. (2026) · Springer eBooks · doi:10.1007/978-3-032-12239-1_5
Behzad, D., Bhakta, K., DeConinck, A., Patel, S., & Ciano, P. D. (2026) · Springer eBooks · doi:10.1007/978-3-032-12239-1_7
Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia
Ku, S.-H., Stringfield, S. J., Torregrossa, M. M., Sweet, R. A., & Chou, S. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20250886
Ramsay, S. D., Hibberd, T. J., Spencer, N. J., & Zagorodnyuk, V. P. (2026) · Autonomic Neuroscience · doi:10.1016/j.autneu.2026.103444
G protein-coupled receptor signaling in osteogenic bone mesenchymal stem/stromal cells
Wolfe, T. J., & Weaver, S. R. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1795445
Anxiolytic and sedative drugs: Sleep modulation and memory implications
Marcoccia, S., Chiacchierini, G., & Campolongo, P. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111793
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-12-816791-5.00001-7
Cannabis use and neurocognitive functioning in adolescents
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8161-2
Copland, R., & Chung, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36773-1.00019-2
Yadav-Samudrala, B. J., Sawaqed, L. E., Huguely, C. J., Lee, W. W. Y., Ravula, H., Orsucci, I. C., Boyer, G., Poklis, J. L., Jiang, W., & Fitting, S. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.112099
Selective GRAB sensors reveal distinct endocannabinoid dynamics in vivoPreprint
Cai, R., Yang, Y., Cai, S., de Sousa, A. I. S., Todd, K. L., Wang, L., Teo, W., Dong, A., Chen, S., Dong, H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.06.743280
Shao, T., Yu, Q., Song, H., Sun, J., Chen, J., Tang, C., Deng, X., Chen, N., Wang, X., Josephson, L., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.08.026
UK Medical Cannabis Registry: An Updated Analysis of Inflammatory Arthritis
Sajeev, A., Erridge, S., Datta, A., Clarke, E., McLachlan, K., Coomber, R., Rucker, J., Platt, M., & Sodergren, M. H. (2026) · Clinical Medicine Insights Arthritis and Musculoskeletal Disorders · doi:10.1177/11795441261480709
Tomer, S., Harding, J. S., Wang, L., Kedia, N., Cook, E., Le, V., Platt, C., Le, J., Tien, N., Patalay, K., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1856131
Fu, Z., Hutchison, K. E., Guha, A., Jing Sui (Beijing Normal University), my correct affiliation is beijing normal university, N. Q. U. O. S. A. T., & Calhoun, V. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04478-5
Salum, K. C. R., de Souza, R. B., Antunes, D., Assis, I. S. D. S., Gouvêa, L. W., Teixeira, M. R., de Melo, M. A. F., Palhinha, L., Abreu, G. D. M., Alves, N. D. S., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1862926
Acupuncture for Autism Spectrum Disorder by Targeting the Endocannabinoid System
Zhou, Y., Yan, Y., & Su, T. (2026) · Acupuncture & Electro-Therapeutics Research · doi:10.1177/03601293261494481
Novel roles of the endocannabinoid system in modulating synaptic plasticity
Angell, A. N. (2008) · The Mathematics Enthusiast
Metadata
- Authors
- Mackie, K.
- Affiliations
- University of Washington (US)
- Corresponding author
- Mackie, K.
- ORCID
- Mackie, K.
- Venue
- Handbook of Experimental Pharmacology
- Publisher
- Springer-Verlag
- Published
- 2005-12-23
- Issue
- 168
- Pages
- 299-325
- OpenAlex
- W2149183149
- Cited by
- 744
- References
- 103
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 47 · 2023: 56 · 2022: 59 · 2021: 69 · 2020: 48 · 2019: 52 · 2018: 40 · 2017: 37 · 2016: 33 · 2015: 31 · 2014: 26 · 2013: 27 · 2012: 32
- FWCI
- 26.30
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Springer eBooks (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA00286, DA11322, R01DA011322, K02DA000286)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- CB1 receptor, cannabinoid receptors, endocannabinoid system, delta-9-tetrahydrocannabinol, G protein-coupled receptors, receptor distribution, central nervous system, peripheral nervous system, hippocampus, amygdala, cerebellum, basal ganglia, neurotransmission
- MeSH terms
- Animals, Autoradiography, Central Nervous System, Humans, Immunohistochemistry, In Situ Hybridization, Peripheral Nervous System, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review